Orli Biger

Orli Biger currently serves as CEO of ARC US and CEO of Liberty Science ARC Health Space 2030, in addition to heading ARC Global at ARC Innovation since May 2022. Previous roles include Chief Business Officer at Reichman University from November 2021 to January 2023 and Business Unit Director at Teva Pharmaceuticals from July 2020 to May 2022. Orli Biger has extensive experience in the pharmaceutical industry, having held various positions at Pfizer and The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on oncology and management roles. Orli Biger's career also includes a background in marketing and sales at MSD, where achievements include leading a successful team and winning awards for effectiveness. Orli Biger's education includes an MBA in Healthcare Innovation from Reichman University, a Master's in Health Systems Management and Public Health from Bar-Ilan University, and a Bachelor's in Medicine and Life Science from Tel Aviv University.